Carlsmed, Inc. (CARL)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $475.46M
Last updated: Nov 17, 2026 at 4:15 PM ET
Carlsmed, Inc. (CARL) Statistics
Carlsmed (CARL) has a market cap of $475.46M and an enterprise value of $454.92M. Its share count is up 29.51% from a year earlier. Revenue grew 60.38% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 4.32% below the market cap, as cash exceeds debt.
| Market Cap | $475.46M |
|---|---|
| Enterprise Value | $454.92M |
| Latest price (Nov 17, 2026) | $17.74 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 10, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 6.7x and 6.4x.
| P/S Ratio | 6.7x |
|---|---|
| Forward P/S | 6.0x |
| P/B Ratio | 6.4x |
Price Statistics
The stock is up 35.32% over 52 weeks and trades 17.87% above its 50-day average.
| Beta (1Y) | 1.55 |
|---|---|
| 52-Week Change | +35.32% |
| 1-Month Change | +29.87% |
| 3-Month Change | +14.30% |
| 6-Month Change | +57.13% |
| Total Return (1Y) | +35.32% |
| Return vs SPY (1Y) | +33.26% |
| Max Drawdown (1Y) | -48.03% |
| Sharpe Ratio (1Y) | 0.50 |
| Correlation with SPY (1Y) | 0.29 |
| 50-Day Average | $15.05 |
| 200-Day Average | $12.60 |
| 52-Week Range | $8.50 to $19.15 |
| RSI (14 Days) | 60.0 |
| Average Volume (20 Days) | 161.13K |
Financial Position
Current assets cover 5.79x current liabilities, and total debt is 0.20x shareholder equity.
| Current Ratio | 5.79x |
|---|---|
| Quick Ratio | 5.62x |
| Debt / Equity | 0.20x |
| Interest Coverage | -33.33x |
Returns and Efficiency
Return on invested capital is -36.71% and return on equity is -52.94% over the last 12 months.
| Return on Equity (ROE) | -52.94% |
|---|---|
| Return on Assets (ROA) | -34.76% |
| Return on Invested Capital (ROIC) | -36.71% |
| Asset Turnover | 0.57x |
| Inventory Turnover | 6.28x |
| Receivables Turnover | 4.68x |
| Cash Conversion Cycle | 59 days |
Scores
CARL has an Altman Z-Score of 6.05, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 6.05 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $71.78M over the last 12 months.
| Revenue | $71.78M |
|---|---|
| Revenue Growth (YoY) | +60.38% |
| Gross Profit | $55.24M |
| Operating Income | -$48.05M |
| Pretax Income | -$46.38M |
| Net Income | -$40.65M |
| Reported EPS (TTM) | -$1.31 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 65.65% of the $115.27M in total assets.
| Cash and Equivalents | $35.95M |
|---|---|
| Total Debt | $15.40M |
| Net Cash | $20.55M |
| Net Cash Per Share | $0.75 |
| Working Capital | $87.32M |
| Shareholder Equity | $75.67M |
| Book Value Per Share | $2.77 |
| Total Assets | $115.27M |
| Total Liabilities | $39.60M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.79M of capital spending, operating cash flow left -$36.15M of free cash flow.
| Operating Cash Flow | -$34.36M |
|---|---|
| Capital Expenditures | $1.79M |
| Free Cash Flow | -$36.15M |
| FCF Per Share | -$1.32 |
| Depreciation and Amortization | $562.00K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -66.95%.
| Gross Margin | 76.96% |
|---|---|
| Operating Margin | -66.95% |
| Pretax Margin | -64.61% |
| Net Margin | -56.63% |
| FCF Margin | -50.36% |
Dividends and Yields
CARL does not pay a dividend. Its free cash flow yield is -7.46%.
| FCF Yield | -7.46% |
|---|---|
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
Peer Position
Against 11 similar companies, CARL has the 2nd highest P/S.
P/S RatioPeer median 2.5x
ROICPeer median 2.72%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.38%
| P/S Ratio | 6.7x vs 2.5x median |
|---|---|
| ROIC | -36.71% vs 2.72% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +60.38% vs +11.38% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About CARL
What is CARL's market cap?
Carlsmed has a market cap of $475.46M. Its enterprise value, which adds debt and subtracts cash, is $454.92M.
How many shares of CARL are outstanding?
Carlsmed has 27.30M shares outstanding. The count is up 29.51% from a year earlier.
Does CARL pay a dividend?
No. Carlsmed does not pay a dividend.
How much debt does CARL have?
Carlsmed has $15.40M of total debt and $35.95M of cash and equivalents, a net cash position of $20.55M.
CARL pages: Overview, Forecast, Statistics, Competitors